Biopharma Stock Updates - 12/09/20

Data Updates:

$GMDA (-13.3%) – Topline phase 3 results & BLA plans

https://investors.gamida-cell.com/news-events/press-releases/news-release-details/gamida-cell-provides-pipeline-update-including

$CYTK (+22.8%) – Phase 2 interim analysis – proceed to cohort 2

https://ir.cytokinetics.com/news-releases/news-release-details/cytokinetics-announces-progression-redwood-hcm-cohort-2

$ATNX (-3.3%) – Updated phase 3 data for oraxol

https://ir.athenex.com/news-releases/news-release-details/athenex-presents-updated-phase-3-data-survival-and-tolerability

$EDIT (+17%) – Submitted IND for EDIT-301 in SCD

https://ir.editasmedicine.com/news-releases/news-release-details/editas-medicine-announces-submission-ind-application-edit-301

$FPRX (-12.5%) – Will present phase 2 data at ASCO 01/15/21

https://investor.fiveprime.com/news-releases/news-release-details/five-prime-present-phase-2-fight-trial-results-bemarituzumab

$GTHX (-7.5%) – Phase 2 data for Triliciclib and phase 1 update

http://investor.g1therapeutics.com/news-releases/news-release-details/g1-therapeutics-presents-final-phase-2-clinical-data-trilaciclib

Financial:

$KURA (-1.2%) – Priced their offering at $37/share

https://ir.kuraoncology.com/news-releases/news-release-details/kura-oncology-announces-pricing-300-million-public-offering

$SNDX (+7%) – Priced their offering at $23/share

http://ir.syndax.com/news-releases/news-release-details/syndax-announces-pricing-public-offering-common-stock-0

$MIRM (+0.67%) - $210 million funding arrangement – tiered revenue-based

https://mirumpharma.gcs-web.com/news-releases/news-release-details/mirum-pharmaceuticals-and-oberland-capital-announce-210-million

0 comments

*Disclaimer: Information provided on bpiq.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Big Movers™ is a trademark of Amp Biotech Research, LLC

©2021 by Biopharm IQ. Website by Awaken Studio.

SITE